News Reviv Global and V-Health hope digital passport will reopen ... Reviv Global and partner V-Health Passport are backing their technology to allow the hospitality industry to reopen safely in resorts such as Las Vegas.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.